Baker Ellis Asset Management LLC
Source: SEC Form 13F · as of Mar 2026Baker Ellis Asset Management LLC holds 13 biotech & pharma companies tracked by BioSniper, totaling $18.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
13
Total value held
$18.2M
| Company | Shares | Value |
|---|---|---|
| SNYSanofi | 83,067 | $4.0M |
| LLYELI LILLY & Co | 3,545 | $3.3M |
| JNJJOHNSON & JOHNSON | 12,665 | $3.1M |
| NVSNovartis AG | 14,950 | $2.3M |
| MRKMerck & Co., Inc. | 14,988 | $1.8M |
| ABBVAbbVie Inc. | 6,083 | $1.3M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 1,852 | $827K |
| CORCencora Inc. | 2,444 | $768K |
| BMYBRISTOL MYERS SQUIBB CO | 4,450 | $270K |
| DGXQuest Diagnostics Incorporated | 1,200 | $235K |
| ABTABBOTT LABORATORIES | 1,999 | $205K |
| ELDNEledon Pharmaceuticals, Inc. | 19,000 | $59K |
| CRDFCardiff Oncology, Inc. | 20,000 | $32K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.